Marathon Fusion Publishes New Pathway for Scalable Production of Promising Cancer-Treatment Isotope Terbium-149

Terbium-149Positive

AI Analysis

Summary

Marathon Fusion announced a novel approach to overcome isotope supply constraints by using a stable gadolinium precursor to enable Terbium-149 production on widely available medical cyclotrons for cancer treatment applications.

Importance:5/10

Sentiment:

0.60

isotope productiononcologymanufacturingterbium-149medical cyclotron

Related Companies

$MDCE

Read the original article

Published by PR Newswire Clinical Trials on September 24, 2026 10:13 AM

Read Original